• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [21597 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2010     Committee for New Health Technology Assessment (CNHTA) [Intraoperative computed tomography for neuronavigation in neurological surgery]
2018     Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) [Intraoperative cholangiography in cholecystectomy]
2006     Canary Health Service [Intraoperative ablation of atrial fibrillation]
2020     Institute for Clinical Effectiveness and Health Policy (IECS) [Intranasal esketamine for severe resistant major depression]
2009     Committee for New Health Technology Assessment (CNHTA) [Intramuscular transplantation of autologous bone marrow stem cell(therapeutic angiogenesis)]
2010     Committee for New Health Technology Assessment (CNHTA) [Intralase Femtosecond (FS) laser for corneal surgery]
2006     Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS ) [Intragastric balloon for treating obesity]
2003     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Intradiscal electrocoagulation therapy (IDET) for chronic back pain]
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Intradialytic parenteral nutrition in patients with chronic kidney conditions]
2015     Institute for Clinical Effectiveness and Health Policy (IECS) [Intracorneal rings for patients with keratoconus]
2008     Committee for New Health Technology Assessment (CNHTA) [Intraarticular PCA(Patient Controlled Analgesia)]
2013     Institute for Clinical Effectiveness and Health Policy (IECS) [Intra-articular use of hyaluronic acid in the treatment of knee osteoarthritis]
2014     Basque Office for Health Technology Assessment (OSTEBA) [Intra-articular injection of platelet-rich plasma for treating knee arthrosis]
2015     Institute for Clinical Effectiveness and Health Policy (IECS) [Intra-articular hyaluronic acid (viscosupplementation) in osteoarthritis]
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Intra-articular hyaluronic acid (viscosupplementation) for osteoarthritis]
2020     Institute for Clinical Effectiveness and Health Policy (IECS) [Intra-arterial chemotherapy for retinoblastoma]
2009     Committee for New Health Technology Assessment (CNHTA) [Intra-abdominal pressure monitoring with abviser]
2015     The Swedish Council on Health Technology Assessment (SBU) [Interventions to prevent misuse of alcohol, drugs and gambling in youth]
2015     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Interventions to improve health-related behaviours of men]
2017     Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) [Interventions to improve foster children’s mental and physical health]
2017     Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) [Interventions to improve foster children's mental and physical health]
2016     Basque Office for Health Technology Assessment (OSTEBA) [Interventions to improve CPAP treatment adherence in patients with obstructive sleep apnea]
2009     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Interventions in young children with obstructive airway diseases]
2007     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Interventions for enhancing medication compliance/adherence with benefits in treatment outcomes]
2007     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Interventions for enhancing medication compliance/adherence with benefits in treatment outcomes]
2007     Basque Office for Health Technology Assessment (OSTEBA) [Interval cancers in the early breast cancer detection programme]
2018     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Interstitial low-dose-rate brachytherapy for localized prostate cancer - rapid report]
2008     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Interstitial brachytherapy in localized prostate cancer]
2010     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Interstitial brachytherapy in localized prostate cancer - rapid report]
2008     Committee for New Health Technology Assessment (CNHTA) [Interspinous posterior lumbar dynamic stabilization]
2008     Committee for New Health Technology Assessment (CNHTA) [Interspinous dynamic stabilization]
2005     Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS ) [Intersomatic fusion techniques of individual or two-level intervertebral for treating degenerative disease of cervical disks]
2009     Andalusian Health Technology Assessment Area (AETSA) [Internet, health and citizenship]
2013     The Swedish Council on Health Technology Assessment (SBU) [Internet-based psychological treatment for anxiety and mood disorders]
2021     Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) [Internet-based psychological treatment for anxiety and depression]
2021     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Internet- or mobile-based cognitive behavioral therapy for insomnia - Evidence report for the S3 guideline on non-restorative sleep/sleep disorders - Insomnia in adults]
2020     Norwegian Institute of Public Health (NIPH) [Intermittent pneumatic compression for preventing deep vein thrombosis in acute stroke, a health technology assessment]
2011     Norwegian Knowledge Centre for the Health Services (NOKC) [Intermediate care units and hospital at home for acute exacerbations of COPD]
2008     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Interferons and natalizumab for multiple sclerosis]
2015     Haute Autorite de sante (HAS) [Interferon-gamma release assays as in vitro screening tests for latent tuberculosis infection]
2010     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Interferon-gamma release assays (IGRAs) for diagnosis of latent tuberculosis infection and active tuberculosis]
2007     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Interdisciplinary follow-up with actors in primary health care]
2007     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Intensive polypharmacological treatment of type 2-diabetes in daily clinical practice - a health technology assessment]
2022     Institute for Clinical Effectiveness and Health Policy (IECS) [Intensity-modulated radiotherapy for prostate cancer]
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Intensity-modulated radiation therapy for breast cancer]
2005     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Intensity modulated radiotherapy]
2012     Institute for Clinical Effectiveness and Health Policy (IECS) [Intensity modulated radiotherapy (IMRT) for prostate cancer]
2011     Institute for Clinical Effectiveness and Health Policy (IECS) [Intensity modulated radiation therapy for three dimensional breast cancer]
2021     Institute for Clinical Effectiveness and Health Policy (IECS) [Intense-pulse-light therapy treatment for dry eye syndrome]
2010     Basque Office for Health Technology Assessment (OSTEBA) [Integrated intra and extra-hospital approach to conduct disorders in adolescence]
2015     Institut national d'excellence en sante et en services sociaux (INESSS) [Insulin pumps in the treatment of type 1 diabetes]
2015     Institute for Clinical Effectiveness and Health Policy (IECS) [Insulin infusion pumps for diabetic patients]
2018     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Insulin glargine/lixisenatide (type 2 diabetes mellitus) - Benefit assessment according to §35a Social Code Book V]
2020     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Insulin glargine/lixisenatide (type 2 diabetes mellitus) - Benefit assessment according to §35a Social Code Book V]
2012     Institute for Clinical Effectiveness and Health Policy (IECS) [Insulin Detemir therapy in pediatric and pregnant population]
2015     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Insulin degludec/liraglutide (new therapeutic indication) - Benefit assessment according to §35a Social Code Book V (dossier assessment)]
2015     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Insulin degludec/liraglutide (Addendum to Commission A15-15)]
2015     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Insulin degludec/liraglutide - Benefit assessment according to §35a Social Code Book V (dossier assessment)]
2015     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Insulin degludec (new therapeutic indication) - Benefit assessment according to §35a Social Code Book V (dossier assessment)]
2019     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Insulin degludec (diabetes mellitus) - Benefit assessment according to §35a Social Code Book V]
2015     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Insulin degludec (addendum to commission A15-10)]
2014     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Insulin degludec - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2015     The Swedish Council on Health Technology Assessment (SBU) [Instruments for suicide risk assessment]
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Inotuzumab ozogamicin (acute lymphocytic leukaemia) - Assessment according to §35a (para. 1., sentence 10) Social Code Book V]
2018     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Inotersen (hereditary transthyretin amyloidosis with polyneuropathy) - Assessment according to §35a (para. 1., sentence 11) Social Code Book V]
2009     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Initial staging of oesophageal cancer: systematic review of the performance of diagnostic methods]
2009     Institute for Clinical Effectiveness and Health Policy (IECS) [Inhaled tobramycin for cystic fibrosis]
2006     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Inhaled insulin (Exubera) in diabetes mellitus - rapid report]
2013     Institute for Clinical Effectiveness and Health Policy (IECS) [Inhalation tobramycin for the management of cystic fibrosis]
2007     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Inguinal hernia: clinical practice guideline]
2012     The Netherlands Organisation for Health Research and Development (ZonMw) [Inguinal hernia management: operation or observation? A randomised controlled multicenter trial]
2018     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ingenol mebutate (actinic keratosis) - Benefit assessment according to §35a Social Code Book V]
2019     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ingenol mebutate (actinic keratosis) - Addendum to Commission A18-55]
2013     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ingenol mebutate - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Infrared meibography for meibomian gland disease]
2011     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Informative value of Patient-Reported Outcomes (PRO) in Health Technology Assessment (HTA)]
2012     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Information, consent and medical counselling on ultrasound screening in pregnancy]
2007     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Information to users on cancer screening in women: assessment of current situation and establishment of evidence-based information standards. 1. Information to users on breast cancer screening]
2010     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Information to users on cancer screening in women: assessment of current situation and establishment of evidence-based information standards 2. Information to users on cervical cancer screening]
2009     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Information to parents about neonatal screening for inborn errors of metabolism: assessment of current situation and establishment evidence-based information standards]
2010     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Information resources: developing user guides]
2006     Basque Office for Health Technology Assessment (OSTEBA) [Information required for analyzing the impact of the early breast cancer detection programme]
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Information for health insurance fund members on ultrasound screening for abdominal aortic aneurysms: addendum to commission S13-04]
2020     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Information for health insurance fund members on prenatal testing]
2015     Institut national d'excellence en sante et en services sociaux (INESSS) [Information brief concerning palliative care day centres]
2009     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Information and communications technologies in mental health (Telepsychiatry)]
2009     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Information and communications technologies in CHF management programmes. Organizational challenges and evidence status]
2008     Committee for New Health Technology Assessment (CNHTA) [Influenza virus A & B, RT-nested PCR]
2021     Health Council of the Netherlands Gezondheidsraad (GR) [Influenza vaccination: review of indications]
2000     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Influenza vaccination of the elderly (funded by DIHTA)]
2022     Canary Health Service [Influenza vaccination in children 6 to 59 months of age]
2009     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Influence of an existing health care plan aimed at managing ST-elevation myocardial infarction on the waiting time until re-perfusion, and types of re-perfusion. Pilot study]
2007     Unit of Health Economics and Technology Assessment in Health Care (HunHTA) [Infliximab in patients with arthritis psoriatic: systematic review of the clinical and economic literature]
2004     Unit of Health Economics and Technology Assessment in Health Care (HunHTA) [Infliximab (REMICADE) in patients with rheumatoid arthritis; systematic review of the clinical and economic literature]
2022     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Inebilizumab (neuromyelitis optica spectrum disorders [NMOSD]) - Benefit assessment according to § 35a SGB V]
2010     The Netherlands Organisation for Health Research and Development (ZonMw) [Induction of labour versus expectant management in women with preterm premature rupture of membranes between 34 and 37 weeks (PPROMEXIL-study)]
2012     The Regional Health Technology Assessment Centre (HTA-centrum) [Induction of labour at 41 completed until 42 completed gestational weeks, update of mini-HTA VGR 2007]
2019     Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval) [Induction immunosuppressive therapy in patients undergoing heart transplantation]
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Induced sputum in severe asthma patients]
2013     Basque Office for Health Technology Assessment (OSTEBA) [Individualised multidisciplinary care programme in frail patients (PAMI)]